Phase 2 Trial to Evaluate Safety & Efficacy of Topical Nitric Oxide Releasing Sinus Irrigation (NOSi) as Compared to Budesonide-Saline (Control) in the Management of Biofilm-Associated Recalcitrant Chronic Rhinosinusitis (RCRS)
Latest Information Update: 05 Jul 2022
At a glance
- Drugs Nitric oxide (Primary) ; Budesonide
- Indications Rhinosinusitis; Sinusitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors SaNOtize Research and Development
Most Recent Events
- 28 Jun 2022 Status changed from recruiting to completed.
- 04 Feb 2021 Planned End Date changed from 30 Jun 2020 to 28 Feb 2022.
- 04 Feb 2021 Planned primary completion date changed from 30 Apr 2020 to 30 Dec 2021.